IMX-Ray™ FDSS
Loading fraud detection platform...
System Active | Medicaid: HHS Provider Spending 2018-2024 (617,503 providers) | Medicare: CMS Part B/D 2024 (10,000 providers) | Updated: March 8, 2026
Sources: CMS, HHS, OIG, NPPES
New here? Start the Guided Demo
16-step walkthrough of IMX-Ray's fraud detection capabilities, from methodology to ROI. ~10 minutes.
Start Demo →
Total Spending
$2.14T
CY 2025 est. Medicare + Medicaid
Total Providers
2,117,503
Unique billing NPIs
Billing Records
3.8B
Combined annual claims
Flagged Providers
0
In sample dataset
Flagged Spending
$0
At-risk amount
Prescribing Alerts
0
Opioid/controlled flags
Payer Adjudication Intelligence ERA/835 Data
Adjudication Tests Active
15
Tests #16-30 (remittance-based)
Denial Pattern Flags
0
Tests #19-21 combined
Payment Anomaly Flags
0
Tests #16,22,28,30
Cross-Payer Flags
0
Tests #24,25

Annual Spending Trend

2018–2024

Top 10 States by Spending

Sample

Risk Distribution

Geographic Risk Density

Top 10 States

Recent Alerts

View All →
Provider NPI State Specialty Total Billed Claims Risk Flags
Back to Search
0

Provider Name

Critical Organization
NPI: 0000000000
Specialty
City, ST
Total Billed
$0
Total Claims
0
Beneficiaries
0

Monthly Spending Trend

Year-over-Year Comparison

Top HCPCS Codes

Code Description Claims Total Paid Cost/Claim Median Ratio

Peer Benchmarking

vs Specialty Peers

Beneficiary Demographics

Affiliations / Network

Fraud Test Results

30 tests

Critical

0

High

0

Elevated

0

Total Flagged

0
Provider State Specialty Total Billed Risk Score Flags Affil. Flagged Flag Details
Total Spending
LowHigh
Providers Shown0
Total Flagged0
At-Risk Spending$0
Cross-State Networks0
Back to States

State Name XX

Total Spending
$0
Providers
0
Flagged
0

Spending by Year

Top Specialties

Top Providers

ProviderSpecialtyTotal BilledRiskFlags

Top Procedures

CodeDescriptionTotal PaidClaims

Top 10 HCPCS Codes by Spending

Code Category Description Total Spending Total Claims Avg Cost/Claim Providers
Clusters Found
0
Total Providers
0
High-Risk Clusters
0
Combined Spending
$0
Cluster Members State Total Spending Shared Beneficiaries Flagged Members Risk Level

Controlled Substance % by Top Prescribers

Opioid Prescribing Rate by Specialty

Provider Specialty State Total Rx Controlled % Opioid % Risk

Spending by Ownership Type

Risk Distribution by Ownership

Corporate Chain Spotlight

ProviderSpecialtyStateTotal BilledRiskFlags
Projected Annual Recovery
$0
Based on flagged spending
Net Annual Savings
$0
After all program costs
Return on Investment
0x
Per dollar invested
Payback Period
0 mo
Time to break even
Model Assumptions
20%
10%ConservativeAggressive50%
GAO reports typical fraud recovery rates of 5-15% of flagged amounts. OIG averages 10-12% on investigated cases.
$5,000
$2KAutomatedFull audit$20K
IMX AI automated investigation procedures. AI-driven analysis reduces per-provider cost vs. traditional manual desk reviews.
30%
5%TargetedComprehensive100%
Most programs investigate the highest-risk providers first. Critical and High-risk tiers typically represent 20-40% of flagged providers.
2%
0%MinimalMature5%
Baseline fraud detection without IMX-Ray. GAO estimates most state Medicaid programs detect only 1-3% of improper payments proactively.
Savings Breakdown
5-Year Projection

Estimates are illustrative projections based on sample dataset extrapolation to national program figures. Actual recovery depends on investigation capacity, legal outcomes, and program-specific factors. Sources: GAO-25-106335, OIG Semi-Annual Report FY 2025, CMS NHE CY 2025 est.

🛡️
SOC 2 Type II
Certified
🔐
AES-256
Encryption at Rest & Transit
📋
NIST 800-53
Control Framework
🏛️
FedRAMP
Roadmap Initiated

System Overview

IMX-Ray™ is a Fraud Detection Decision Support System (FDSS) designed for federal and state agencies responsible for Medicaid program integrity. The system applies advanced statistical analytics, machine learning, and real-time data integration to identify anomalous billing patterns, high-risk providers, and potential fraud, waste, and abuse (FWA) across the Medicaid ecosystem.

Data Architecture

IMX-Ray™ is powered by IMX Data's proprietary healthcare claims repository, one of the largest commercially available datasets in the United States:

  • 100+ billion healthcare claims processed
  • 300+ million unique patient records
  • $1.17 trillion in annual Medicare expenditures analyzed (CMS Actuaries CY 2025 est.)
  • $971.4 billion in annual Medicaid expenditures analyzed (CMS-64 preliminary CY 2025)
  • 617,503 unique billing provider NPIs tracked
  • 227 million Medicaid billing records in current analysis set
  • 9 live CMS data feeds integrated for real-time enrichment

Primary data sources include the HHS T-MSIS (Transformed Medicaid Statistical Information System), CMS NPPES NPI Registry, CMS-64 State Expenditure Reports, OIG LEIE Exclusion Database, Open Payments, Hospital Compare, Nursing Home Compare, and State Drug Utilization data.

Analytical Capabilities

The system employs 30 validated statistical tests organized across nine detection categories:

Claims Submission Tests (#1-15)

  • Volume Anomaly Detection: Identifies providers with statistically significant deviations in claims volume, beneficiary counts, and billing frequency relative to specialty and geographic peers.
  • Cost Anomaly Detection: Flags outlier reimbursement patterns including per-claim cost deviations, rate anomalies, and disproportionate spending relative to service mix.
  • Pattern Recognition: Detects suspicious billing patterns including single-code concentration, temporal consistency anomalies, Benford's Law violations, and systematic upcoding indicators.
  • Growth Anomaly Detection: Identifies explosive billing growth, rapid volume escalation, and new-entrant risk patterns commonly associated with fraudulent operations.
  • External Reference Matching: Cross-references OIG Exclusion List, revoked provider databases, and enforcement action histories.
  • Prescribing Analytics: Monitors controlled substance and opioid prescribing rates against specialty benchmarks and geographic norms.

Payer Adjudication Tests (#16-30)

  • Payment Pattern Analysis: Detects charge-to-payment ratio outliers, allowed amount manipulation, and patient responsibility anomalies using ERA/835 remittance data.
  • Denial and Resubmission Analysis: Identifies denial rate outliers, reason code concentration, and denial-and-resubmit cycling patterns indicative of organized billing fraud.
  • Payment Velocity and Timing: Flags payment velocity anomalies, service-to-statement lag, payer-specific billing divergence, and Medicare-Medicaid reimbursement arbitrage.
  • DRG and Facility Analysis: Detects DRG upcoding, discharge fraction anomalies, and contractual adjustment outliers across inpatient facilities.
  • Reversal and Correction Patterns: Monitors reversal/correction frequency and payer-initiated reduction patterns that indicate systemic overbilling.

Risk Classification Framework

Each provider receives a composite Fraud Risk Score (0-100) based on the weighted severity and count of triggered detection flags. Classification tiers align with investigative prioritization:

  • Critical (70-100): Immediate investigation recommended. Multiple severe flags indicating high probability of billing anomalies.
  • High (40-69): Priority review. Several concerning indicators warranting detailed examination.
  • Elevated (15-39): Monitoring recommended. Flags present but lower severity; may reflect legitimate practice variations.
  • Standard (0-14): No significant anomalies. Billing patterns within expected parameters.

Important: Risk scores are investigative leads, not determinations of fraud. All flagged providers require human review by qualified investigators before any enforcement action.

Investigation Support Features

  • Provider Deep-Dive: Comprehensive profiles including billing history, HCPCS code analysis, peer comparison, and risk factor breakdown
  • Network Analysis: Maps provider affiliations and shared beneficiary patterns to identify coordinated fraud schemes
  • Geographic Intelligence: Heat-map visualization of fraud density by state and region with drill-down capability
  • Case Study Library: Documented analysis of major fraud schemes (Operation Gold Rush, Wound Care Networks, MA Upcoding) with detection methodology
  • Real-Time CMS Integration: Live data feeds from 9 CMS endpoints for current provider verification and enrichment
  • PDF Report Generation: Export investigation-ready fraud risk assessments with full provider analysis and supporting data

Deployment Options

Configuration Description Data Scope
SaaS, Multi-tenant Cloud-hosted, IMX-managed infrastructure. SOC 2 certified. Full 100B+ claim and adjudication events dataset
SaaS, Dedicated Isolated tenant with dedicated compute and storage. Full dataset + custom feeds
On-Premises Deployed within agency network boundary. FedRAMP-aligned. Agency-specified scope
GovCloud AWS GovCloud (US) or Azure Government deployment. Full dataset, ITAR-compliant

Data Sources & Integrations

HHS T-MSIS Medicaid Spending Dataset

2.7 billion annual claims, $971.4 billion (CY 2025 est.), 617,503 NPIs. T-MSIS data covering all 50 states, DC, and territories. CMS-64 preliminary spending, HMA analysis January 2026.

CMS NPPES NPI Registry

Real-time provider identity verification. NPI-validated provider records including names, addresses, specialties, and organizational affiliations via the National Plan and Provider Enumeration System.

CMS-64 State Expenditure Reports

State-level Medicaid spending calibration. FY 2023 quarterly financial data for geographic distribution weighting and state-level aggregate validation.

OIG LEIE Exclusion Database

Office of Inspector General List of Excluded Individuals/Entities. Real-time cross-referencing against known sanctioned providers and excluded entities.

CMS Synthetic Medicare Claims (DE-SynPUF)

2.3 million synthetic Medicare claims across carrier, inpatient, outpatient, DME, HHA, hospice, SNF, and Part D. 13,408 unique providers, $4.24 billion in simulated spending. Access via the CMS Live Data view.

About IMX Data

IMX Data (imxresearch.com) operates one of the largest commercially available healthcare claims databases in the United States, processing over 100 billion claim and adjudication events representing 300+ million patients. The company provides data analytics, fraud detection, and healthcare intelligence solutions to federal agencies, state Medicaid programs, health plans, and research institutions.

IMX Data holds SOC 2 Type II certification and maintains security controls aligned with NIST SP 800-53. FedRAMP authorization is in progress.

For inquiries: imxresearch.com · This system contains evaluation data. Contact IMX Data for production deployment with full 100B+ claim and adjudication events dataset access.

Email

jim@imxresearch.com

For demos, pricing, and partnership inquiries

Website

www.imxresearch.com

Company information and data products

Request a Demo or Proposal

Complete the form below and we will respond within one business day.

Deployment Options

☁️
SaaS
Cloud-hosted, IMX-managed
🏛️
GovCloud
AWS GovCloud / Azure Gov
🔒
On-Premises
Within agency network boundary
Type to search providers, states, or procedures...